The global market for Radioisotopes is estimated to be valued as $9.61 billion in 2015 and is expected to reach $17.28 billion by the end of 2020. During this period of forecast the market is expected to grow at a CAGR of 12.45%.

Major driving factors for the growth of the market are increasing demand of SPECT analysis in radiopharmaceuticals, development of better instruments, newer computer based procedures for image analysis and display, new 99mTc labeled agents for visualizing biologically significant events, increasing demand of PET analysis in radiopharmaceuticals, increasing use in clinical applications to study psychiatric disorders. Integration of X-ray tomography (CT) into SPECT has recently emerged as a brilliant diagnostic tool in medical imaging and is considered to be a driving factor for the growth of the market.

To read more please visit: http://www.businesswire.com/news/home/20160725005671/en/Global-Nuclear-Medicine-Radioisotopes-Market-Worth-USD

Source: Business wire